These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4397179)

  • 1. Analysis of the action of m-tyrosine on blood pressure in the conscious rat: evidence for a central hypotensive effect.
    Rubenson A
    J Pharm Pharmacol; 1971 Jun; 23(6):412-9. PubMed ID: 4397179
    [No Abstract]   [Full Text] [Related]  

  • 2. Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the rat.
    Henning M; Rubenson A
    J Pharm Pharmacol; 1970 Aug; 22(8):553-60. PubMed ID: 4394527
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline.
    Henning M; Rubenson A
    J Pharm Pharmacol; 1971 Jun; 23(6):407-11. PubMed ID: 4397178
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the mode of action of alpha-methyldopa.
    Henning M
    Acta Physiol Scand Suppl; 1969; 322():1-37. PubMed ID: 4311985
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.
    Andén NE; Corrodi H; Fuxe K
    J Pharm Pharmacol; 1972 Mar; 24(3):177-82. PubMed ID: 4402775
    [No Abstract]   [Full Text] [Related]  

  • 6. 4,4,6-trimethyl-3,4-dihydropyrimidine-2-thiol, an effective inhibitor of dopamine-beta-hydroxylation in vivo.
    Porter CC; Torchiana ML
    Biochem Pharmacol; 1971 Jan; 20(1):183-91. PubMed ID: 4398314
    [No Abstract]   [Full Text] [Related]  

  • 7. The normal occurrence of octopamine in the central nervous system of the rat.
    Buck SH; Murphy RC; Molinoff PB
    Brain Res; 1977 Feb; 122(2):281-97. PubMed ID: 13909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aterial blood pressure in dogs: effects of m-tyrosine alone or in combination with inhibitors of aromatic amino acid decarboxylase; relative hypotensive potencies of L-dopa, DL-m-tyrosine, and L-m-tyrosine.
    Minsker DH; Stokes AL
    Experientia; 1974 Sep; 30(9):1051-3. PubMed ID: 4412113
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats.
    Kuruma I; Bartholini G; Tissot R; Fletscher A
    J Pharm Pharmacol; 1972 Apr; 24(4):289-94. PubMed ID: 4402836
    [No Abstract]   [Full Text] [Related]  

  • 10. Central tyramine prevents hypertension in uninephrectomized DOCA-saline treated rats.
    Shalita B; Dikstein S
    Experientia; 1977 Nov; 33(11):1430-1. PubMed ID: 923698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of tyramine-3H and octopamine-3H by rat brain.
    Breese GR; Chase TN; Kopin IJ
    Biochem Pharmacol; 1969 Apr; 18(4):863-9. PubMed ID: 4389230
    [No Abstract]   [Full Text] [Related]  

  • 12. Further studies on the mechanism of the central hypotensive effect of L-dopa, DL-m-tyrosine and L-alpha-methyldopa.
    Rubenson A
    J Pharm Pharmacol; 1971 Mar; 23(3):228-30. PubMed ID: 4396899
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
    Corrodi H; Fuxe K
    Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of L-DOPA and analogues on central dopamine and noradrenaline mechanisms.
    Andén NE; Engel J
    Adv Neurol; 1974; 5():317-24. PubMed ID: 4613158
    [No Abstract]   [Full Text] [Related]  

  • 15. Regional distribution and metabolism of H3-tyramine in the rat brain.
    Goldstein M; Anagnoste B; Yamamoto A; Felch WC
    J Pharmacol Exp Ther; 1970 Feb; 171(2):196-204. PubMed ID: 4391786
    [No Abstract]   [Full Text] [Related]  

  • 16. Metatyrosine-induced reversal of the suppression of the conditioned avoidance response in reserpine-treated rats.
    Engel J
    Acta Pharmacol Toxicol (Copenh); 1971; 30(3):278-88. PubMed ID: 4945487
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of apomorphine on motility in rats.
    Maj J; Grabowska M; Gajda L
    Eur J Pharmacol; 1972 Feb; 17(2):208-14. PubMed ID: 5026397
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.
    Henning M
    Acta Pharmacol Toxicol (Copenh); 1969; 27(2):135-48. PubMed ID: 5819569
    [No Abstract]   [Full Text] [Related]  

  • 19. L-DOPA induced effects on motor activity in mice after inhibition of dopamine-beta-hydroxylase.
    Strömberg U; Svensson TH
    Psychopharmacologia; 1971; 19(1):53-60. PubMed ID: 5089105
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of aromatic amino acid decarboxylase and depletion of biogenic amines in brain of rats treated with alpha-monofluoromethyl p-tyrosine: similitudes and differences with the effects of alpha-monofluoromethyldopa.
    Jung MJ; Hornsperger JM; Gerhart F; Wagner J
    Biochem Pharmacol; 1984 Jan; 33(2):327-30. PubMed ID: 6704155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.